Clinical Study of Tripterygium Capsule to Treat Early Ankylosing Spondylitis
Status:
Unknown status
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
This study is a 12-week, randomized, placebo and positive drug controlled clinical trial to
investigate whether tripterygium capsule is effective and safe in treating patients with
ankylosing spondylitis. The investigators expect that the tripterygium capsule is more
effective than placebo and has few adverse effects.